Skip to content

Lasers

Elite iQ (Cynosure)

Cynosure, LLC

FDA-cleared device (510(k)) — cleared, not approvedChecked Oct 19, 2026 · Read on the pages cited

What it is

Maker
Cynosure, LLC
Category
Lasers
Also called
Elite iQ, Elite IQ

FDA status

Pathway
FDA-cleared device (510(k)) — cleared, not approved
First approved or cleared
2020

Research notes

Clearance letter and 510(k) summary opened 2026-10-19. K193426, trade name Elite iQ, Cynosure LLC, letter dated March 9, 2020, substantially equivalent, 21 CFR 878.4810, Class II, product code GEX. Indications are the summary's intended-use section. The summary's sponsor conclusion about performance is not copied. K240396 was opened only through the letter heading: trade name Elite iQ PRO (M122K1), letter dated March 8, 2024, same regulation and product code. Its indications are not recorded on this entry. An earlier automated association with K223447 was an unrelated CT scanner and stays discarded.

What it’s authorized for

As recorded from the FDA record and labeling cited below.

  • 755 nm: The Elite iQ Laser System is indicated for stable long-term or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 or 12 months after the completion of a treatment regime. It is used for skin types (Fitzpatrick I-VI) including tanned skin. It is also indicated for the treatment of vascular lesions, benign pigmented lesions, and wrinkles.
  • 1064 nm: The Elite iQ Laser System is intended for the coagulation and hemostasis of benign vascular lesions such as, but not limited to, port wine stains, hemangiomas, warts, telangiectasia, rosacea, venous lakes, leg veins, spider veins and poikiloderma of Civatte; and treatment of benign cutaneous lesions such as warts, scars, striae and psoriasis. The laser is also intended for the treatment of benign pigmented lesions such as, but not limited to, lentigines (age spots), solar lentigines (sunspots), cafe au lait macules, seborrheic keratoses, nevi, chloasma, verrucae, skin tags, keratosis and plaques. The laser is also indicated for the treatment of wrinkles such as, but not limited to, periocular and perioral wrinkles. Additionally, the laser is indicated for the treatment of pseudo folliculitis barbae (PFB) and for stable long-term or permanent hair reduction. Permanent hair reduction is defined as long-term stable reduction in the number of hairs regrowing when measured at 6, 9 and 12 months after the completion of a treatment regime.
  • The Skintel Reader is intended as an objective measurement tool for examining skin melanin content for determining and setting a test spot starting fluence.

How it’s sold

Prescription. The summary describes a dual-wavelength workstation, Alexandrite 755 nm and Nd:YAG 1064 nm, and says an Alexandrite-only workstation is also available under this submission.

Not interchangeable

The K193426 letter names Elite iQ. It does not name Elite iQ PRO. A separate letter, K240396, dated March 8, 2024, names Elite iQ PRO (M122K1). The K193426 summary names Cynosure Elite+ (K141425) as a predicate, which is a different device.

What the label warns about

No label warning is recorded here. That isn’t the same as the label having none — the research notes and sources say what was opened.

Checking it’s the real thing

No FDA authenticity notice is recorded for this product.

Ask in the room

“What’s the brand name printed on the box, vial or device panel — and may I see it?”

Recalls and enforcement

FDA recall and enforcement records filed under K193426, read live from openFDA. A recall usually covers particular models or lots, not every unit ever made.

Searching FDA recall and enforcement records by this product’s FDA number…

Look up K193426 and a number from the box

Check it yourself

Device proof ladder: The room sells a laser, RF, microneedling, body-contouring, light, or other hardware result. Work down in order — each step needs the one before it.

  1. Read the panelGet the exact manufacturer and model from the device itself.
  2. Find the authorizationSearch 510(k) and De Novo by model/manufacturer, not treatment nickname.510(k) Premarket Notification database (opens in a new tab) · U.S. Food & Drug Administration
  3. Match identityUse AccessGUDID when a UDI or device identifier is available.AccessGUDID (opens in a new tab) · FDA / National Library of Medicine
  4. Read maker instructionsCompare the proposed use with current manufacturer labeling/IFU for that exact model.
  5. Check post-market recordSearch recalls/corrections after the model is known.Medical Device Recalls (opens in a new tab) · U.S. Food & Drug Administration
  6. Verify the operatorThen check the person's applicable state credential and device-specific training.

Worth knowing

What an FDA record can and can’t tell you

FDA records show what was authorized, for what, and when.

They can never show that the product in the room is authentic, in date, stored properly, or being used for its authorized purpose. Those are questions for the room.

Sources

Treatments that use it

No treatment guide lists this product yet.

Product identity

Told a name? Shown a box?

Type what was said or printed, see whether it matches a registry entry, and note what you saw in your booking file.

Check a name